Guest guest Posted October 4, 2004 Report Share Posted October 4, 2004 http://www.sciencedirect.com/science?_ob=ArticleURL & _udi=B6T8P- 4D8V948-1 & _coverDate=09%2F30% 2F2004 & _alid=206367164 & _rdoc=1 & _fmt= & _orig=search & _qd=1 & _cdi=5092 & _so rt=d & view=c & _acct=C000050221 & _version=1 & _urlVersion=0 & _userid=10 & md5= c39047bdaa2a3dd85d7512985693cd4a The Journal of Nutritional Biochemistry Volume 15, Issue 9 , September 2004, Pages 506-516 doi:10.1016/j.jnutbio.2004.05.002 Copyright © 2004 Elsevier Inc. All rights reserved. Review: Current topic Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases Orly Weinreba, Silvia Mandela, Tamar Amita and Moussa B. H. Youdim, , a a Eve Topf and USA National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research and Department of Pharmacology, Rappaport Family Research Institute, Technion-Faculty of Medicine, 31096, Haifa, Israel Received 8 March 2004; Revised 10 May 2004; accepted 26 May 2004. Available online 9 September 2004. Abstract Tea consumption is varying its status from a mere ancient beverage and a lifestyle habit, to a nutrient endowed with possible prospective neurobiological–pharmacological actions beneficial to human health. Accumulating evidence suggest that oxidative stress resulting in reactive oxygen species generation and inflammation play a pivotal role in neurodegenerative diseases, supporting the implementation of radical scavengers, transition metal (e.g., iron and copper) chelators, and nonvitamin natural antioxidant polyphenols in the clinic. These observations are in line with the current view that polyphenolic dietary supplementation may have an impact on cognitive deficits in individuals of advanced age. As a consequence, green tea polyphenols are now being considered as therapeutic agents in well controlled epidemiological studies, aimed to alter brain aging processes and to serve as possible neuroprotective agents in progressive neurodegenerative disorders such as Parkinson's and Alzheimer's diseases. In particular, literature on the putative novel neuroprotective mechanism of the major green tea polyphenol, ( & #8722;)-epigallocatechin-3-gallate, are examined and discussed in this review. FAIR USE NOTICE: This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www4.law.cornell.edu/uscode/17/107.html If you wish to use copyrighted material from this site for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.